What is CVE-2018-14789?

CVE-2018-14789 is a medium-severity vulnerability in Philips Intellispace Cardiovascular, classified under Unquoted Search Path or Element. CVSS score: 6.7/10. Published 2018-08-22.

How severe is CVE-2018-14789?

Medium severity. CVSS v3 base score is 6.7 out of 10.

Vulnerability in Philips Intellispace Cardiovascular

CVE-2018-14789

In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 3.1 or prior and Xcelera Version 4.1 or prior), an unquoted search path or element vulnerability has been identified, which may allow an attacker to execute arbitrary code and escalate their level of privileges.

Published 2018-08-22 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 6.7 (Medium). Vector: CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.004 (36.3th percentile), scored 2026-09-29.

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 36th percentile — 36.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000

Affected products

Philips Intellispace Cardiovascular
Philips Intellispace Cardiovascular (Iscv) Products — versions IntelliSpace Cardiovascular, Version 3.1 or prior, Xcelera Version 4.1 or prior
Philips Xcelera

Weakness classification (CWE)

CWE-428 — Unquoted Search Path or Element

References

www.usa.philips.com/healthcare/about/customer-support/product-security (Vendor Advisory)
ics-cert.us-cert.gov/advisories/ICSMA-18-226-01 (US Government Resource, Third Party Advisory)

Frequently asked questions

What is CVE-2018-14789?: CVE-2018-14789 is a medium-severity vulnerability in Philips Intellispace Cardiovascular, classified under Unquoted Search Path or Element. CVSS score: 6.7/10. Published 2018-08-22.
How severe is CVE-2018-14789?: Medium severity. CVSS v3 base score is 6.7 out of 10.